tiprankstipranks
Matinas BioPharma (MTNB)
NYSE MKT:MTNB

Matinas BioPharma (MTNB) Balance Sheet

1,443 Followers

Matinas BioPharma Balance Sheet

Matinas BioPharma's total assets for Q4 2023 were $25.10M, a decrease of -15.73% from the previous quarter. MTNB total liabilities were $5.86M for the fiscal quarter, a -11.79% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 25.10M$ 44.82M$ 61.33M$ 70.97M$ 40.24M
Total Liabilities
$ 5.86M$ 8.18M$ 8.83M$ 7.24M$ 7.19M
Total Equity Gross Minority
$ 19.25M$ 36.64M$ 52.49M$ 63.73M$ 33.05M
Total Capitalization
$ 22.14M$ 40.19M$ 52.49M$ 63.73M$ 33.05M
Preferred Stock Equity
---$ 3.80M$ 3.99M
Capital Lease Obligations
---$ 3.75M$ 4.23M
Currency in USD

Matinas BioPharma Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis